289
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis, Antimicrobial Evaluation, and Molecular Docking of New Azole, Azine, Thiazole, and Chromene Derivatives

ORCID Icon, , , &
Pages 3429-3449 | Received 04 Nov 2021, Accepted 14 Apr 2022, Published online: 24 May 2022
 

Abstract

Novel heterocyclic compounds containing a benzothiazole moiety (2–16) were synthesized via the reaction of benzothiazole cyanoacetamide derivative (2) with different types of reagents. All compounds were characterized by 1H NMR, MS, and IR techniques. The newly synthesized compounds were examined for their in vitro antibacterial activity against Gram-positive bacteria (Bacillus subtilis and Staphylococcus aureus), Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa), and fungi (Candida albicans) microorganisms. Compounds (5, 6, 7, and 15) are promising antimicrobial agents and could be the lead compounds for more potent drugs. Binding modes of the synthesized compounds were analyzed by docking studies that showed good binding scores against the diverse amino acids of the two selected proteins (PDB Codes – 2EXB and 3HUN). The conducted docking studies were found to be consistent with antimicrobial results. Thus, the results indicate that the designed structures can be a potential lead as antimicrobial agents.

Disclosure statement

The authors declare no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.